Načítá se...
Anticoagulation and bleeding risk in patients with COVID-19
BACKGROUND: There is no current standardized approach to anticoagulation in patients with Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study characterizes the patterns of anticoagulation use in COVID-19 patients and the risk of related bleeding. METHODS: This is a s...
Uloženo v:
| Vydáno v: | Thromb Res |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Ltd.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7444469/ https://ncbi.nlm.nih.gov/pubmed/32916565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.thromres.2020.08.035 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|